Nuvation Bio Financial Statements
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nuvation Bio revenue and earnings
In fiscal 2025, Nuvation Bio generated $62.9 million in revenue, up 699.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Nuvation Bio reported a net loss of $204.6 million, compared with a loss of $567.9 million a year earlier. Operating margin was -338.7%.
Diluted earnings per share came in at -$0.60.
Summary generated from market data by MetaCap's automated system. Methodology
Nuvation Bio income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 62.90M | 7.87M | 0 | — | — | — |
| Revenue growth (YoY) | +698.96% | — | — | — | — | — |
| Cost of Revenue | — | 7.08M | 0 | — | — | — |
| Gross Profit | — | 795.00K | 0 | — | — | — |
| Operating Expenses | 275.97M | 600.50M | 99.82M | 119.73M | 93.32M | 43.55M |
| Research & Development | 115.11M | 99.12M | 71.29M | 87.81M | 69.04M | 32.60M |
| Selling, General & Admin | 151.56M | 69.23M | 28.53M | — | — | — |
| Operating Income | -213.06M | -592.63M | -99.82M | -119.73M | -93.32M | -43.55M |
| Interest Expense | 13.68M | 341.00K | 0 | — | — | — |
| Other Income (Expense) | 8.44M | 24.69M | 24.02M | 15.54M | 6.47M | 1.89M |
| Pretax Income | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M | -41.66M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M | -41.66M |
| Net Income growth (YoY) | — | — | — | — | — | — |
| EPS (Basic) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.43 |
| EPS (Diluted) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.43 |
| Shares Outstanding (Basic) | 341.54K | 268.77K | 218.88K | 216.72K | 197.89K | 97.53M |
| Shares Outstanding (Diluted) | 341.54K | 268.77K | 218.88K | 216.72K | 197.89K | 97.53M |
| EBITDA | -211.32M | -591.94M | -99.60M | -119.53M | -93.13M | -43.45M |
| Gross Margin | — | 10.10% | — | — | — | — |
| Operating Margin | -338.72% | -7527.33% | — | — | — | — |
| Net Margin | -325.31% | -7213.76% | — | — | — | — |
This table shows 6 annual periods of Nuvation Bio's income statement, from FY 2025 back to FY 2020, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow NUVB's reporting calendar. What is a income statement?